CME Group Inc [CME] stock prices are down -0.82% to $252.37 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CME shares have lost -4.87% over the last week, with a monthly amount drifted -0.86%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CME Group Inc [NASDAQ: CME] stock has seen the most recent analyst activity on March 10, 2025, when Raymond James upgraded its rating to a Outperform but kept the price target unchanged to $287 for it. Previously, Citigroup downgraded its rating to Neutral on January 06, 2025, and dropped its price target to $250. On October 08, 2024, downgrade downgraded it’s rating to Neutral but maintained its price target of $244 on the stock. RBC Capital Mkts started tracking the stock assigning a Sector Perform rating and suggested a price target of $235 on September 27, 2024. TD Cowen initiated its recommendation with a Hold and recommended $221 as its price target on September 26, 2024. BofA Securities downgraded its rating to Underperform for this stock on September 03, 2024, and downed its price target to $177. In a note dated June 21, 2024, JP Morgan downgraded an Underweight rating on this stock and revised its target price from $206 to $187.
The stock price of CME Group Inc [CME] has been fluctuating between $186.08 and $273.42 over the past year. Currently, Wall Street analysts expect the stock to reach $258.67 within the next 12 months. CME Group Inc [NASDAQ: CME] shares were valued at $252.37 at the most recent close of the market. An investor can expect a potential return of 2.5% based on the average CME price forecast.
Analyzing the CME fundamentals
The CME Group Inc [NASDAQ:CME] reported sales of 6.13B for trailing twelve months, representing a surge of 5.98%. Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at 0.64%, Pretax Profit Margin comes in at 0.74%, and Net Profit Margin reading is 0.57%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.13 and Total Capital is 0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 248.55 points at the first support level, and at 244.73 for the second support level. However, for the 1st resistance point, the stock is sitting at 257.80, and for the 2nd resistance point, it is at 263.24.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 14.84, the price to book ratio is 3.43 and price to earnings (TTM) ratio is 26.09.
Transactions by insiders
Recent insider trading involved SHEPARD WILLIAM R, Director, that happened on Mar 26 ’25 when 263.0 shares were purchased. Director, SHEPARD WILLIAM R completed a deal on Mar 26 ’25 to buy 12.0 shares. Meanwhile, Director Lucas Deborah J sold 1500.0 shares on Mar 14 ’25.
